372.7 USD
+3.19 (+0.86%)
BRKRP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKRP while its profitability can be described as average. BRKRP is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BRKRP was profitable.
BRKRP had a positive operating cash flow in the past year.
BRKRP had positive earnings in each of the past 5 years.
Each year in the past 5 years BRKRP had a positive operating cash flow.
1.2 Ratios
BRKRP has a better Return On Assets (-0.37%) than 63.79% of its industry peers.
Looking at the Return On Equity, with a value of -0.97%, BRKRP is in the better half of the industry, outperforming 63.79% of the companies in the same industry.
BRKRP's Return On Invested Capital of 4.01% is fine compared to the rest of the industry. BRKRP outperforms 67.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKRP is below the industry average of 13.53%.
The last Return On Invested Capital (4.01%) for BRKRP is well below the 3 year average (9.30%), which needs to be investigated, but indicates that BRKRP had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKRP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.99%, BRKRP is in the better half of the industry, outperforming 63.79% of the companies in the same industry.
BRKRP's Operating Margin has declined in the last couple of years.
BRKRP has a Gross Margin (48.00%) which is in line with its industry peers.
BRKRP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BRKRP is destroying value.
BRKRP has more shares outstanding than it did 1 year ago.
BRKRP has less shares outstanding than it did 5 years ago.
BRKRP has a worse debt/assets ratio than last year.
2.2 Solvency
BRKRP has an Altman-Z score of 9.89. This indicates that BRKRP is financially healthy and has little risk of bankruptcy at the moment.
BRKRP has a Altman-Z score of 9.89. This is amongst the best in the industry. BRKRP outperforms 91.38% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that BRKRP is somewhat dependend on debt financing.
BRKRP has a worse Debt to Equity ratio (0.82) than 75.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 9.89 |
ROIC/WACC0.4
WACC10.11%
2.3 Liquidity
A Current Ratio of 1.85 indicates that BRKRP should not have too much problems paying its short term obligations.
BRKRP has a Current ratio of 1.85. This is in the lower half of the industry: BRKRP underperforms 63.79% of its industry peers.
A Quick Ratio of 0.89 indicates that BRKRP may have some problems paying its short term obligations.
BRKRP's Quick ratio of 0.89 is on the low side compared to the rest of the industry. BRKRP is outperformed by 89.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The earnings per share for BRKRP have decreased strongly by -18.37% in the last year.
BRKRP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
Looking at the last year, BRKRP shows a small growth in Revenue. The Revenue has grown by 6.10% in the last year.
Measured over the past years, BRKRP shows a quite strong growth in Revenue. The Revenue has been growing by 10.19% on average per year.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
BRKRP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.96% yearly.
Based on estimates for the next years, BRKRP will show a small growth in Revenue. The Revenue will grow by 3.14% on average per year.
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.96%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y3.14%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 186.35, BRKRP can be considered very expensive at the moment.
BRKRP's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.46, BRKRP is valued quite expensively.
BRKRP is valuated quite expensively with a Price/Forward Earnings ratio of 161.45.
The rest of the industry has a similar Price/Forward Earnings ratio as BRKRP.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.10, BRKRP is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 186.35 | ||
| Fwd PE | 161.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKRP is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 111.32 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)20.82
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
5. Dividend
5.1 Amount
With a yearly dividend of 0.41%, BRKRP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.45, BRKRP pays a better dividend. On top of this BRKRP pays more dividend than 91.38% of the companies listed in the same industry.
With a Dividend Yield of 0.41, BRKRP pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of BRKRP has a limited annual growth rate of 4.81%.
BRKRP is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)4.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
The earnings of BRKRP are negative and hence is the payout ratio. BRKRP will probably not be able to sustain this dividend level.
The dividend of BRKRP is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
BRUKER CORP - BRKR 6 3/8 09/01/28
NASDAQ:BRKRP (12/4/2025, 8:07:03 PM)
372.7
+3.19 (+0.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.43%
Inst Owner ChangeN/A
Ins Owners26.98%
Ins Owner ChangeN/A
Market Cap56.63B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts76.19
Price Target368.7 (-1.07%)
Short Float %0.01%
Short Ratio0.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)-4.74%
PT rev (3m)N/A
EPS NQ rev (1m)-23.28%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.24%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-3.6%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 186.35 | ||
| Fwd PE | 161.45 | ||
| P/S | 16.47 | ||
| P/FCF | N/A | ||
| P/OCF | 600.51 | ||
| P/B | 23.29 | ||
| P/tB | N/A | ||
| EV/EBITDA | 111.32 |
EPS(TTM)2
EY0.54%
EPS(NY)2.31
Fwd EY0.62%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY0.17%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)20.82
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 9.89 |
F-Score5
WACC10.11%
ROIC/WACC0.4
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.96%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y3.14%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.97%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP - BRKR 6 3/8 09/01/28 / BRKRP FAQ
What is the fundamental rating for BRKRP stock?
ChartMill assigns a fundamental rating of 3 / 10 to BRKRP.
Can you provide the valuation status for BRUKER CORP - BRKR 6 3/8 09/01/28?
ChartMill assigns a valuation rating of 1 / 10 to BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP - BRKR 6 3/8 09/01/28?
BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) has a profitability rating of 5 / 10.
What is the valuation of BRUKER CORP - BRKR 6 3/8 09/01/28 based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is 186.35 and the Price/Book (PB) ratio is 23.29.
Can you provide the expected EPS growth for BRKRP stock?
The Earnings per Share (EPS) of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is expected to decline by -17.24% in the next year.